122 related articles for article (PubMed ID: 31765777)
1. Hydrophobic H-bond pairing: A novel approach to improve membrane permeability.
Nazir I; Shahzadi I; Jalil A; Bernkop-Schnürch A
Int J Pharm; 2020 Jan; 573():118863. PubMed ID: 31765777
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?
Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V
Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838
[TBL] [Abstract][Full Text] [Related]
3. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
Kamei N; Morishita M; Ehara J; Takayama K
J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
[TBL] [Abstract][Full Text] [Related]
4. Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate.
Efiana NA; Dizdarević A; Huck CW; Bernkop-Schnürch A
J Pharm Sci; 2019 Oct; 108(10):3329-3339. PubMed ID: 31136766
[TBL] [Abstract][Full Text] [Related]
5. Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release.
Nazir I; Asim MH; Dizdarević A; Bernkop-Schnürch A
Int J Pharm; 2019 Apr; 561():197-205. PubMed ID: 30836151
[TBL] [Abstract][Full Text] [Related]
6. About the impact of superassociation of hydrophobic ion pairs on membrane permeability.
Shahzadi I; Nazir I; Nhu Quynh Phan T; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2020 Jun; 151():1-8. PubMed ID: 32268189
[TBL] [Abstract][Full Text] [Related]
7. Preparation and investigation of mefenamic acid - polyethylene glycol - sucrose ester solid dispersions.
Fülöp I; Gyéresi Á; Kiss L; Deli MA; Croitoru MD; Szabó-Révész P; Aigner Z
Acta Pharm; 2015 Dec; 65(4):453-62. PubMed ID: 26677901
[TBL] [Abstract][Full Text] [Related]
8. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
[TBL] [Abstract][Full Text] [Related]
9. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
10. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
Griesser J; Hetényi G; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 Mar; 520(1-2):267-274. PubMed ID: 28188875
[TBL] [Abstract][Full Text] [Related]
12. Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats.
Zheng Y; Qiu Y; Lu MF; Hoffman D; Reiland TL
Int J Pharm; 1999 Aug; 185(1):83-92. PubMed ID: 10425368
[TBL] [Abstract][Full Text] [Related]
13. Development and in vivo evaluation of a new oral nanoparticulate dosage form for leuprolide based on polyacrylic acid.
Iqbal J; Vigl C; Moser G; Gasteiger M; Perera G; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):432-40. PubMed ID: 21557716
[TBL] [Abstract][Full Text] [Related]
14. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
15. Effects of sucrose ester structures on liposome-mediated gene delivery.
Zhao Y; Liu A; Du Y; Cao Y; Zhang E; Zhou Q; Hai H; Zhen Y; Zhang S
Acta Biomater; 2018 May; 72():278-286. PubMed ID: 29609051
[TBL] [Abstract][Full Text] [Related]
16. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
[TBL] [Abstract][Full Text] [Related]
17. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
18. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes.
Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM
Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057
[TBL] [Abstract][Full Text] [Related]
19. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the impact of multivalent metal ions on the permeation behavior of Dolutegravir sodium.
Grießinger JA; Hauptstein S; Laffleur F; Netsomboon K; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2016; 42(7):1118-26. PubMed ID: 26552713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
